Marisa D’Angeli

612 total citations
18 papers, 276 citations indexed

About

Marisa D’Angeli is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Marisa D’Angeli has authored 18 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Medicine, 7 papers in Applied Microbiology and Biotechnology and 5 papers in Epidemiology. Recurrent topics in Marisa D’Angeli's work include Antibiotic Use and Resistance (7 papers), Antibiotic Resistance in Bacteria (7 papers) and Urinary Tract Infections Management (3 papers). Marisa D’Angeli is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Antibiotic Resistance in Bacteria (7 papers) and Urinary Tract Infections Management (3 papers). Marisa D’Angeli collaborates with scholars based in United States. Marisa D’Angeli's co-authors include Scott J. Weissman, Meagan Kay, Kaye Eckmann, Jeffrey S. Duchin, Christopher Baliga, Kristen Wendorf, Andrew S. Ross, Michael Glück, Punam Verma and David Tirschwell and has published in prestigious journals such as Clinical Infectious Diseases, Emerging infectious diseases and MMWR Morbidity and Mortality Weekly Report.

In The Last Decade

Marisa D’Angeli

16 papers receiving 261 citations

Peers

Countries citing papers authored by Marisa D’Angeli

Since Specialization

Citations

This map shows the geographic impact of Marisa D’Angeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa D’Angeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa D’Angeli more than expected).

Fields of papers citing papers by Marisa D’Angeli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa D’Angeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa D’Angeli. The network helps show where Marisa D’Angeli may publish in the future.

Co-authorship network of co-authors of Marisa D’Angeli

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa D’Angeli. A scholar is included among the top collaborators of Marisa D’Angeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa D’Angeli. Marisa D’Angeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Community-associated New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales: multiple states, from September 2021 through September 2022 2025 ·Infection Control and Hospital Epidemiology ·Sophie Jones, Richard A. Stanton, Marisa D’Angeli, (unknown), (unknown), (unknown), Shermalyn R. Greene, (unknown), (unknown), (unknown), (unknown), (unknown), Maroya Spalding Walters	1
2	Integrating Genomic Data into Public Health Surveillance for Multidrug-Resistant Organisms, Washington, USA 2025 ·Emerging infectious diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), Marisa D’Angeli, (unknown), Claire Brostrom-Smith, (unknown), (unknown), (unknown), Josefa León, (unknown), Philip Dykema, (unknown), Allison Black	1
3	Prescribing Patterns of High Opioid and Antibiotic Prescribers, Washington State, 2021: Do Some Prescribers Have Trouble Saying No? 2024 ·Open Forum Infectious Diseases ·David Evans, (unknown), (unknown), Marisa D’Angeli, (unknown)	1
4	Outpatient Antibiotic Resistance Patterns of Escherichia coli Urinary Isolates Differ by Specialty Type 2022 ·Microbiology Spectrum ·(unknown), Scott J. Weissman, Hema Kapoor, Marisa D’Angeli, (unknown), Jeff Radcliff, Peter Rabinowitz	3
5	Finding the path of least resistance: Locally adapting the MITIGATE toolkit in emergency departments and urgent care centers 2021 ·Infection Control and Hospital Epidemiology ·(unknown), (unknown), (unknown), (unknown), Rupali Jain, Jeannie D. Chan, John B. Lynch, Marisa D’Angeli, Larissa May, Chloe Bryson‐Cahn	4
6	Antimicrobial Resistance Patterns of Urinary Escherichia coli Among Outpatients in Washington State, 2013–2017: Associations With Age and Sex 2021 ·Clinical Infectious Diseases ·(unknown), Scott J. Weissman, Hema Kapoor, Marisa D’Angeli, (unknown), Jeff Radcliff, Peter Rabinowitz	8
7	Surveillance for Antibiotic-Resistant E. coli in the Salish Sea Ecosystem 2021 ·Antibiotics ·(unknown), Marilyn C. Roberts, (unknown), J. E. West, Stephanie A. Norman, Dyanna M. Lambourn, (unknown), Ryan Ruiz, Marisa D’Angeli, Scott J. Weissman, Peter Rabinowitz	13
8	Statewide surveillance of carbapenemase-producing carbapenem-resistant Escherichia coli and Klebsiella species in Washington state, October 2012–December 2017 2020 ·Infection Control and Hospital Epidemiology ·Mimi R. Precit, (unknown), (unknown), Scott J. Weissman, (unknown), (unknown), Marisa D’Angeli	3
9	143. Initial Impact of COVID-19 on Ambulatory Antibiotic Prescribing for Respiratory Viral Infections 2020 ·Open Forum Infectious Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), John B. Lynch, Larissa May, (unknown), Marisa D’Angeli, Chloe Bryson‐Cahn	1
10	Hepatitis C Virus Potentially Transmitted by Opioid Drug Diversion from a Nurse — Washington, August 2017–March 2018 2019 ·MMWR Morbidity and Mortality Weekly Report ·Henry Njuguna, (unknown), Patricia C. Montgomery, Nigel E. Turner, Marisa D’Angeli, (unknown), (unknown), Cathy R. Wasserman, Sumathi Ramachandran, (unknown), Danae Bixler, Kiran M. Perkins, Isaac Benowitz, Anne C. Moorman	7
11	Leveraging Technology to Increase Public Awareness of the Importance of Antimicrobial Stewardship 2019 ·American Journal of Infection Control ·(unknown), Marisa D’Angeli	1
12	Notes from the Field: Clinical Klebsiella pneumoniae Isolate with Three Carbapenem Resistance Genes Associated with Urology Procedures — King County, Washington, 2018 2019 ·MMWR Morbidity and Mortality Weekly Report ·Kirsten Vannice, (unknown), (unknown), Claire Brostrom-Smith, Patricia C. Montgomery, Meagan Kay, Maroya Spalding Walters, (unknown), Marisa D’Angeli, Jeff Duchin	7
13	University of Washington Tele-Antimicrobial Stewardship Program (UW-TASP/ECHO): Collaboration Across Washington State to Improve Antimicrobial Use 2017 ·Open Forum Infectious Diseases ·Yuan Zhou, John B. Lynch, Paul S. Pottinger, John D. Scott, Laura A.S. Quilter, Marisa D’Angeli, (unknown), Rupali Jain, Robert J. Cybulski, (unknown)	5
14	Antimicrobial stewardship through a one health lens 2016 ·International Journal of Health Governance ·Marisa D’Angeli, (unknown), Douglas R. Call, Margaret A. Davis, (unknown), Uma Malhotra, (unknown), Dale A. Moore, (unknown), Paul S. Pottinger, Virginia O. Stockwell, C. Wagner, Ron Wohrle, Jonathan Yoder, (unknown), Peter Rabinowitz	8
15	Endoscopic Retrograde Cholangiopancreatography–Associated AmpCEscherichia coliOutbreak 2015 ·Infection Control and Hospital Epidemiology ·Kristen Wendorf, Meagan Kay, Christopher Baliga, Scott J. Weissman, Michael Glück, Punam Verma, Marisa D’Angeli, (unknown), (unknown), Kaye Eckmann, Andrew S. Ross, Jeffrey S. Duchin	152
16	Acute Neuromuscular Weakness in a Boy With a Facial Abscess Contaminated With Clostridium Botulinum 2012 ·The Pediatric Infectious Disease Journal ·(unknown), (unknown), (unknown), Marisa D’Angeli, Marcia Goldoft, Denny Russell, Robert C. Atkins	0
17	Environmental Factors Associated With Childhood-Onset Type 1 Diabetes Mellitus 2010 ·Archives of Pediatrics and Adolescent Medicine ·Marisa D’Angeli, Eugene Merzon, (unknown), David Tirschwell, Carolyn A. Paris, Beth A. Mueller	59
18	Intratracheal administration of pulmonary vasodilator agents 1992 ·Pediatric Pulmonology ·Marisa D’Angeli, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact